David M. Baratz

Pulmonary Medicine
2000 S Thompson St
Flagstaff, AZ 86001

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis.

A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis.

Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: September 22, 2023
Showing 1-1 of 1

Last Updated: 09/26/2026